Skip to main content

Publisher: Bentham Science Publishers

More about this publication?
Volume 7, Number 8, 2007

Articles

Snake Venom Phospholipase A2 Inhibitors: Medicinal Chemistry and Therapeutic Potential
pp. 743-756(14)
Authors: Marcussi, Silvana; Sant'Ana, Carolina D.; Oliveira, Clayton Z.; Quintero Rueda, Aristides; Menaldo, Danilo L.; Beleboni, Rene O.; Stabeli, Rodrigo G.; Giglio, Jose R.; M. Fontes, Marcos R.; Soares, Andreimar M.

Favourites:
ADD

Structural Elements of Ligand Recognition Site in Secretory Phospholipase A2 and Structure-Based Design of Specific Inhibitors
pp. 757-764(8)
Authors: Singh, Nagendra; Somvanshi, Rishi K.; Sharma, Sujata; Dey, Sharmistha; Kaur, Punit; Singh, Tej P.

Favourites:
ADD

PLA2 Mediated Arachidonate Free Radicals: PLA2 Inhibition and Neutralization of Free Radicals by Anti-Oxidants - A New Role as Anti-Inflammatory Molecule
pp. 765-777(13)
Authors: Nanda, B. L.; Nataraju, A.; Rajesh, R.; Rangappa, K. S.; Shekar, M. A.; Vishwanath, B. S.

Favourites:
ADD
Favourites:
ADD

Chemistry and Structural Evaluation of Different Phospholipase A2 Inhibitors in Arachidonic Acid Pathway Mediated Inflammation and Snake Venom Toxicity
pp. 787-800(14)
Authors: Narendra Sharath Chandra, J. N.; Ponnappa, K. C.; Sadashiva, C. T.; Priya, B. S.; Nanda, B. L.; Veerabasappa Gowda, T.; Vishwanath, B. S.; Rangappa, K. S.

Favourites:
ADD

Group IIA Secretory PLA2 Inhibition by Ursolic Acid: A Potent Anti-Inflammatory Molecule
pp. 801-809(9)
Authors: Nataraj, A.; Raghavendra Gowda, C. D.; Rajesh, R.; Vishwanath, B. S.

Favourites:
ADD

Synthesis and Evaluation of Tricyclic Dipyrido Diazepinone Derivatives as Inhibitors of Secretory Phospholipase A2 with Anti-Inflammatory Activity
pp. 811-820(10)
Authors: Thimmegowda, N. R.; Dharmappa, K. K.; Ananda kumar, C. S.; Sadashiva, M. P.; Sathish, A. D.; Nanda, B. L.; Vishwanath, B. S.; Rangappa, K. S.

Favourites:
ADD

Molecule of the Month
pp. 821-821(1)
Author: Anne Myers, Kari

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content